TCL Archive IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed. By Cancer History Project April 16, 2010
TCL Archive ASCO Urges Doubling Cooperative Group Program Budget By Cancer History Project April 16, 2010
TCL Archive FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011 By Cancer History Project April 16, 2010
TCL Archive Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients. By Cancer History Project April 9, 2010
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. By Cancer History Project April 9, 2010
TCL Archive Report Urges Changes To Cut Activation Times For NCI Phase III Trials. By Cancer History Project April 9, 2010
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
Primary Source Backwater to Blockbuster: St. Jude Children’s Research Hospital By Cancer History Project
